US53000N1081 - ADR
LIANBIO-ADR
NASDAQ:LIAN (3/18/2024, 8:21:48 PM)
After market: 0.32 +0 (+0.31%)0.319
-0.03 (-8.28%)
LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. The company is headquartered in Princeton, New Jersey and currently employs 163 full-time employees. The company went IPO on 2021-10-28. The firm is focused on developing and commercializing medicines for patients with unmet medical needs, with a focus on in-licensing assets for Greater China and other Asian markets. The company has a pipeline of eight therapeutic candidates across cardiovascular, oncology, ophthalmology, and inflammatory disease indications. Its product candidates include Mavacamten, TP-03, NBTXR3, Infigratinib, BBP-398, Omilancor, NX-13 and LYR-210. Mavacamten is an oral small-molecule allosteric modulator of cardiac myosin, which is approved for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) and is also being studied as a treatment for other diseases of diastolic dysfunction. TP-03 is a topical ophthalmic formulation of lotilaner, that is used for the treatment of demodex blepharitis (DB) and meibomian gland disease (MGD). NBTXR3 is a radio enhancer for the treatment of head and neck cancer and other solid tumors.
LIANBIO-ADR
103 Carnegie Center Drive, Suite 309, Suite 215
Princeton NEW JERSEY
P: 16094862308
Employees: 163
Website: https://www.lianbio.com/
LianBio stock is incredibly volatile on Friday as heavy trading rocks LIAN amid plans for a voluntary delisting of the shares.
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!
LianBio plans to voluntarily delist its ADSs from Nasdaq and expects to be quoted on the OTC Markets Group Inc., ensuring continued trading.
LianBio (LIAN) declares $4.80/share special dividend. Payable March 11; for shareholders of record Feb. 27; ex-div Feb. 26. See LIAN Dividend Scorecard, Yield C
联拓生物将开始关闭其业务,包括出售剩余资产和裁员、从纳斯达克退市以及发放特别现金股息...
Here you can normally see the latest stock twits on LIAN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: